Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Dec 12, 2022 12:59pm
115 Views
Post# 35166434

RE:RE:Just sell the company

RE:RE:Just sell the companyThere are things that can be done now (not related  to the Plan)to show that they consider the SP tto be ridiculously low,
1-Massive insider buying
2-Granting options at an exercise price higher or at least equal to the SP before the Pause was announced
3-Pre announce 4 th Quarter sales



Wino115 wrote: Hard to watch these days, but they will end and company will have a plan that should inject some level of reality into the situation. They have every incentive to do so and none not to discuss what they're all planning now once they agree on that plan.

Last I saw an analysis of, for example, just EGRIFTA, if you took todays sales and only grew them 5% and discounted at 8% for just 10-12 years, you'd have a value today of something in the $250m to $300m level based on free cash flow because the margins are very high. Those are rough numbers from one of the reports that escapes me  I'm not sure the Trogarzo number, but maybe half that or something based on lower margins. That's whats been said by the analysts and how even the most pessimistic analyst gets a $3 fundamental valuation, not that it means much in an emotional puke. They need to show a way to net cashflow and the underlying value of the company would start to support it again like those numbers would show. Even at pretty flat growth the profits would be there with cost declines. 

Trogarzon wrote: I am at a point where I want the company to be sold and I don't want to join the hope convoy for the next 5 years.  I also do not want to sell below 3$.  To put it in simple words I want my money now and don't want to let them restart another 5 year cycle to the next thing.  Been there done that.  Let send our CEO pursue other exciting ventures and hire Marathon to sell the dam thing.




<< Previous
Bullboard Posts
Next >>